Clinical Trial Update: Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating bevacizumab with chemoradiation followed by gemcitabine and bevacizumab for locally advanced pancreatic cancer has been te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Bevacizumab (Avastin) (bevacizumab)
• Gemzar (gemcitabine) (gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma | Phase 1, Phase 2 | Status: TERMINATED